United States' factor XI-deficiency patients need a safer treatment

Louis M. Aledort; Jenny Goudemand; Jeannie Callum; Viviane Guerin; G. Kenet; Man Chiu Poon; Olivier Spertini; Mari Thomas

doi:10.1002/ajh.20565

United States' factor XI-deficiency patients need a safer treatment

Louis M. Aledort, Jenny Goudemand, Jeannie Callum, Viviane Guerin, G. Kenet, Man Chiu Poon, Olivier Spertini, Mari Thomas

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

A replacement factor for Factor XI with is virally inactivated is not available in the U.S. Elsewhere an inactivated concentrate has been used. A review of the experience over 15 years suggests that this product is safe and effective and suggests its potential use in the U.S. The most serious complication of the factor was a slight increase in DIC and thrombotic events.

Original language	English
Pages (from-to)	301-302
Number of pages	2
Journal	American Journal of Hematology
Volume	80
Issue number	4
DOIs	https://doi.org/10.1002/ajh.20565
State	Published - Dec 2005

Access to Document

10.1002/ajh.20565

Cite this

@article{d70912913d204ebaa5cfe4f73744dc1c,

title = "United States' factor XI-deficiency patients need a safer treatment",

abstract = "A replacement factor for Factor XI with is virally inactivated is not available in the U.S. Elsewhere an inactivated concentrate has been used. A review of the experience over 15 years suggests that this product is safe and effective and suggests its potential use in the U.S. The most serious complication of the factor was a slight increase in DIC and thrombotic events.",

author = "Aledort, {Louis M.} and Jenny Goudemand and Jeannie Callum and Viviane Guerin and G. Kenet and Poon, {Man Chiu} and Olivier Spertini and Mari Thomas",

year = "2005",

month = dec,

doi = "10.1002/ajh.20565",

language = "English",

volume = "80",

pages = "301--302",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - United States' factor XI-deficiency patients need a safer treatment

AU - Aledort, Louis M.

AU - Goudemand, Jenny

AU - Callum, Jeannie

AU - Guerin, Viviane

AU - Kenet, G.

AU - Poon, Man Chiu

AU - Spertini, Olivier

AU - Thomas, Mari

PY - 2005/12

Y1 - 2005/12

N2 - A replacement factor for Factor XI with is virally inactivated is not available in the U.S. Elsewhere an inactivated concentrate has been used. A review of the experience over 15 years suggests that this product is safe and effective and suggests its potential use in the U.S. The most serious complication of the factor was a slight increase in DIC and thrombotic events.

AB - A replacement factor for Factor XI with is virally inactivated is not available in the U.S. Elsewhere an inactivated concentrate has been used. A review of the experience over 15 years suggests that this product is safe and effective and suggests its potential use in the U.S. The most serious complication of the factor was a slight increase in DIC and thrombotic events.

UR - http://www.scopus.com/inward/record.url?scp=28544441971&partnerID=8YFLogxK

U2 - 10.1002/ajh.20565

DO - 10.1002/ajh.20565

M3 - Review article

C2 - 16315257

AN - SCOPUS:28544441971

SN - 0361-8609

VL - 80

SP - 301

EP - 302

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 4

ER -

United States' factor XI-deficiency patients need a safer treatment

Abstract

Access to Document

Fingerprint

Cite this